Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-078840
Filing Date
2025-08-14
Accepted
2025-08-14 19:47:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12041
  Complete submission text file 0001104659-25-078840.txt   13833
Mailing Address 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024
Business Address 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024 858-224-9600
KIORA PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

EIN.: 980443284 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88748 | Film No.: 251221948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738
Business Address 3503 WILD CHERRY DRIVE BUILDING 9 AUSTIN TX 78738 512-254-3790
ADAR1 Capital Management, LLC (Filed by) CIK: 0001940272 (see all company filings)

EIN.: 000000000 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13G/A